Related Experiment Videos

Reduced adiponectin level is associated with severity of coronary artery disease

Kazuo Hara1, Toshimasa Yamauchi, Yasushi Imai

  • 1Department of Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Japan.

International Heart Journal
|April 6, 2007
PubMed

Insights

Low plasma adiponectin levels are linked to more severe coronary artery disease. Measuring adiponectin may help predict coronary artery stenosis severity in patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Syndrome

Background:

  • Adiponectin, an adipocyte-derived hormone, exhibits antiatherosclerotic properties independent of its antidiabetic effects.
  • Reduced plasma adiponectin levels are frequently observed in individuals with coronary artery disease (CAD).

Purpose of the Study:

  • To investigate the association between plasma adiponectin levels and the severity of coronary artery disease.
  • To evaluate the correlation between adiponectin and the Gensini score, a measure of coronary artery stenosis.

Main Methods:

  • The study included 104 patients undergoing coronary angiography.
  • Plasma adiponectin levels were measured and correlated with the insulin resistance index (HOMA-IR) and the Gensini score.
  • Statistical analysis was performed, including adjustments for conventional cardiovascular risk factors.

Main Results:

  • Plasma adiponectin levels showed an inverse correlation with HOMA-IR (P = 0.0127).
  • A significant association was found between plasma adiponectin levels and the Gensini score (P = 0.0332).
  • After adjusting for cardiovascular risk factors, a trend towards an inverse correlation between adiponectin and Gensini score persisted (P = 0.087).

Conclusions:

  • Plasma adiponectin levels are associated with the severity of coronary artery stenosis.
  • Adiponectin measurement could serve as a potential biomarker for predicting coronary artery stenosis severity.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...